Contact this trialFirst, we need to learn more about you.
Chemotherapy
Tomivosertib for Non Small Cell Lung Cancer
Recruiting0 awardsPhase 2
Eugene, Oregon
This trial tests a combination of two drugs, Tomivosertib and pembrolizumab, in patients with a specific type of lung cancer. Pembrolizumab is a targeted therapy that has been approved for treating this type of cancer. The trial aims to enhance the immune system's ability to fight cancer, especially in those who haven't been treated yet or whose cancer has worsened despite previous treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service